Dr. Pierre Kory offers remarks about the evolution of treatments in face of the rise of the delta variant, and discusses the upcoming revisions in the FLCCC protocols, including the MASK+ early treatment and the MATH+ hospital-level treatment protocols. Dr. Kory also comments on particularly important aspects, such as the unfortunate lack of continuity in the treatments if patients get admitted in hospital.